Recently, BOC Sciences announced that it will provide a variety of ADC cytotoxins to accelerate the development of ADCs.
Shirley, United States - October 29, 2020 /MarketersMedia/ —
Recently, BOC Sciences, a leading supplier in the pharmaceutical industry, announced that it will provide a variety of ADC cytotoxins to accelerate the development of ADCs.
ADC is a targeting agent composed of monoclonal antibodies, linkers, and cytotoxins. ADC cytotoxin is a cytotoxic agent, also known as payload, which can induce the death of target cells in antibody-drug conjugates (ADC). ADC cytotoxin is the most important component of ADC because it determines the ability to kill ADC cancer cells.
According to the mechanism of action of ADC cytotoxin, they can be divided into DNA damaging agents and tubulin inhibitors. There are many cytotoxins currently being used, including Calicheamicins, Duocarmycins, Pyrrolobenzodiazepines (PBD), Camptothecins, Daunorubicin/Doxorubicin, Auristatin, and Maytansinoids, etc. In addition to the cytotoxins listed above, there are many traditional cytotoxic agents that have similar mechanisms to kill cancer cells and can also be used in the development of ADCs.
Relying on the GMP synthesis platform and extensive ADC development & synthesis experience, BOC Sciences can provide more than 800 high-quality ADC cytotoxins, which can be used to develop ADC drugs with different mechanisms of action. All BOC Sciences’ products are purified by HLPC.
About BOC Sciences
BOC Sciences is dedicated to the discovery and development of RNAi therapeutics. The company's mission is to provide cost-effective products and services to its global customers to promote their innovation in molecular discovery. For more information, please visit https://adc.bocsci.com.
Contact Info:
Name: Alex Brown
Email: Send Email
Organization: BOC Sciences
Address: 45-16 Ramsey Road Shirley, NY 11967, USA
Website: https://www.bocsci.com
Source: MarketersMedia
Release ID: 88982628
